AngioDynamics, Inc. Proceeds from Stock Plans
AngioDynamics, Inc. (ANGO) reported Proceeds from Stock Plans of $950.00 thousand for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2026-04-02
- AngioDynamics, Inc. proceeds from stock plans for the quarter ending 2026-02-28 was $716.00K, a 20.00% decline year-over-year.
- AngioDynamics, Inc. proceeds from stock plans for the quarter ending 2025-11-30 was $0.00.
- AngioDynamics, Inc. proceeds from stock plans for the quarter ending 2025-08-31 was $234.00K, a 444.19% increase year-over-year.
- AngioDynamics, Inc. proceeds from stock plans for the quarter ending 2025-02-28 was $895.00K, a 28.96% increase year-over-year.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month |
|---|---|---|---|
| 2026-02-28 | $716.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-02 | $716.00K derived: sum of 2 quarters · filed 2026-04-02 | $950.00K 10-Q · filed 2026-04-02 |
| 2025-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-06 | $234.00K 10-Q · filed 2026-01-06 | |
| 2025-08-31 | $234.00K 10-Q · filed 2025-10-02 | ||
| 2025-02-28 | $895.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-02 | $890.00K derived: sum of 2 quarters · filed 2026-04-02 | $933.00K 10-Q · filed 2026-04-02 |
| 2024-11-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-06 | $38.00K 10-Q · filed 2026-01-06 | |
| 2024-08-31 | $43.00K 10-Q · filed 2025-10-02 | ||
| 2024-02-29 | $694.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-02 | $342.00K derived: sum of 2 quarters · filed 2025-04-02 | $752.00K 10-Q · filed 2025-04-02 |
| 2023-11-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-08 | $58.00K 10-Q · filed 2025-01-08 | |
| 2023-08-31 | $410.00K 10-Q · filed 2024-10-03 | ||
| 2023-02-28 | $941.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $1.09M derived: sum of 2 quarters · filed 2024-04-09 | $1.17M 10-Q · filed 2024-04-09 |
| 2022-11-30 | $148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-08 | $230.00K 10-Q · filed 2024-01-08 | |
| 2022-08-31 | $82.00K 10-Q · filed 2023-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |